Generali Asset Management SPA SGR Has $1.67 Million Stock Holdings in Veeva Systems Inc. $VEEV

Key Points

• Generali Asset Management SPA SGR reduced its stake in Veeva Systems by 61.8%, holding 5,796 shares worth approximately $1.67 million as of its most recent SEC filing.
• Insiders at Veeva Systems have sold 24,665 shares in the last three months, with significant transactions from both an insider and a senior vice president resulting in major decreases in their positions.
• Several analysts have increased their target prices for Veeva Systems, with Wells Fargo raising it from $300 to $326 and Piper Sandler from $325 to $355, showing a generally positive outlook for the stock.

Generali Asset Management SPA SGR reduced its stake in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 61.8% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 5,796 shares of the technology company's stock after selling 9,357 shares during the period. Generali Asset Management SPA SGR's holdings in Veeva Systems were worth $1,669,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in VEEV. Abound Financial LLC acquired a new stake in shares of Veeva Systems during the first quarter worth $25,000. ORG Partners LLC bought a new position in Veeva Systems during the 1st quarter worth about $26,000. Trust Co. of Toledo NA OH acquired a new stake in shares of Veeva Systems in the 2nd quarter valued at about $29,000. Golden State Wealth Management LLC lifted its holdings in shares of Veeva Systems by 152.9% in the first quarter. Golden State Wealth Management LLC now owns 129 shares of the technology company's stock valued at $30,000 after purchasing an additional 78 shares in the last quarter. Finally, Wayfinding Financial LLC acquired a new position in shares of Veeva Systems during the first quarter worth about $32,000. Institutional investors and hedge funds own 88.20% of the company's stock.

Insider Buying and Selling

In related news, insider Eleni Nitsa Zuppas sold 6,000 shares of the business's stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the transaction, the insider directly owned 25,325 shares of the company's stock, valued at approximately $7,765,151.50. The trade was a 19.15% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jonathan Faddis sold 14,595 shares of the firm's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total value of $4,378,500.00. Following the sale, the senior vice president directly owned 8,588 shares of the company's stock, valued at $2,576,400. This represents a 62.96% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 24,665 shares of company stock valued at $7,438,000. 10.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on VEEV shares. Wells Fargo & Company boosted their target price on Veeva Systems from $300.00 to $326.00 and gave the company an "overweight" rating in a research note on Tuesday, August 26th. William Blair reissued an "outperform" rating on shares of Veeva Systems in a research report on Friday. Piper Sandler raised their target price on shares of Veeva Systems from $325.00 to $355.00 and gave the company an "overweight" rating in a research report on Thursday, August 28th. KeyCorp boosted their price target on shares of Veeva Systems from $285.00 to $325.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. Finally, Oppenheimer restated an "outperform" rating and set a $325.00 price objective on shares of Veeva Systems in a research note on Thursday, August 28th. Seventeen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Veeva Systems has a consensus rating of "Moderate Buy" and an average price target of $307.58.

Veeva Systems Price Performance

Shares of VEEV opened at $283.96 on Friday. The company has a market cap of $46.54 billion, a PE ratio of 58.31, a price-to-earnings-growth ratio of 2.26 and a beta of 0.98. The firm has a 50-day moving average of $283.44 and a 200-day moving average of $266.73. Veeva Systems Inc. has a one year low of $201.54 and a one year high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last issued its earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.90 by ($0.64). Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The firm had revenue of $789.08 million during the quarter, compared to the consensus estimate of $768.49 million. During the same period in the previous year, the company posted $1.62 earnings per share. The firm's revenue for the quarter was up 16.7% compared to the same quarter last year. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Analysts expect that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.